搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按时间排序
按相关度排序
Stacker on MSN
22 小时
The myth about laxatives you need to stop believing
Ro shares the skinny on laxatives for weight loss, as well as better ways to lose weight sustainably and safely.
Healio
1 天
FDA approves Datroway for advanced breast cancer
The FDA approved datopotamab deruxtecan-dlnk for treatment of certain patients with advanced breast cancer.The indication ...
Knowridge
4 天
How to manage IBS in older adults
Irritable Bowel Syndrome, or IBS, is a common condition that affects the digestive system. It causes symptoms like stomach ...
Joplin Globe
5 天
DATROWAY® Approved in the U.S. for Patients with Previously Treated Metastatic HR Positive ...
DATROWAY ® (datopotamab deruxtecan-dlnk) has been approved in the U.S. for the treatment of adult patients with unresectable or metastatic hormone receptor (HR) positive, HER2 negative (IHC 0, IHC 1+ ...
Fox 9
5 天
Ozempic, cancer treatments among 15 drugs to be negotiated by Medicare for lower prices
Tradjenta -- A prescription medicine that is used to treat type 2 diabetes. Otezla – A prescription pill that treats plaque ...
5 天
on MSN
Xifaxan selected for CMS drug price talks in 2027
LAVAL, QC - Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a pharmaceutical company with a market capitalization of $2.81 ...
Joplin Globe
6 天
CALQUENCE® (acalabrutinib) plus chemoimmunotherapy approved in the US for patients with ...
CALQUENCE® (acalabrutinib) plus chemoimmunotherapy approved in the US for patients with previously untreated mantle cell lymphoma ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈